Literature DB >> 26476136

Long-term results following an anatomically based surgical technique for resection of colon cancer: a comparison with results from complete mesocolic excision.

L Bokey1,2, P H Chapuis3,4, C Chan5,6, P Stewart3, M J F X Rickard3, A Keshava3,4, O F Dent1,2,3,4.   

Abstract

AIM: Complete mesocolic excision (CME) has been advocated as likely to improve the long-term oncological outcome of colon cancer resection, although there is a paucity of long-term results in the literature. The aim of this study was to supplement our previously published results on colon cancer resection based on a standardized technique of precise dissection along anatomical planes with high vascular ligation and to compare our long-term results with those of recent European studies of CME.
METHOD: Data were drawn from a prospective hospital registry of consecutive resections for colon cancer between 1996 and 2007, including follow-up to the end of 2012. The principal outcomes from potentially curative resections were 5-year Kaplan-Meier rates of local recurrence, systemic recurrence, overall survival and cancer-specific survival. Secondary outcomes for all resections were postoperative complications, number of lymph nodes retrieved and R0 status.
RESULTS: For 779 potentially curative resections the local recurrence rate was 2.1% (95% CI 1.3-3.4), the systemic recurrence rate was 10.2% (95% CI 8.1-12.7), the 5-year overall survival rate was 76.2% (95% CI 73.0-79.0) and the cancer-specific survival rate was 89.8% (95% CI 87.3-91.9). For all 905 resections, rates of 14 surgical complications were low and not dissimilar to those in a comparable study. The median lymph node count was 15 (range 0-113). R0 status was confirmed in 883/905 patients (97.6%; 95% CI 96.4-98.5).
CONCLUSION: For colon cancer, meticulous dissection along anatomical planes together with high vascular ligation results in few complications, a high R0 rate, low recurrence and high survival. Colorectal Disease
© 2015 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  Complete mesocolic excision; recurrence; survival

Mesh:

Year:  2016        PMID: 26476136     DOI: 10.1111/codi.13159

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  9 in total

1.  Laparoscopic Complete Mesocolic Excision for Right-Sided Colon Cancer: Analysis of Feasibility and Safety from a Single Western Center.

Authors:  Corrado Pedrazzani; Enrico Lazzarini; Giulia Turri; Eduardo Fernandes; Cristian Conti; Valeria Tombolan; Filippo Nifosì; Alfredo Guglielmi
Journal:  J Gastrointest Surg       Date:  2018-11-14       Impact factor: 3.452

2.  Laparoscopic complete mesocolic excision via mesofascial separation for left-sided colon cancer.

Authors:  Shinichiro Mori; Yoshiaki Kita; Kenji Baba; Masayuki Yanagi; Kan Tanabe; Yasuto Uchikado; Hiroshi Kurahara; Takaaki Arigami; Yoshikazu Uenosono; Yuko Mataki; Akihiro Nakajo; Kosei Maemura; Shoji Natsugoe
Journal:  Surg Today       Date:  2017-08-23       Impact factor: 2.549

3.  Introduction of complete mesocolic excision with central vascular ligation as standardized surgical treatment for colon cancer in Greece. Results of a pilot study and bi-institutional cooperation.

Authors:  Aristotelis Perrakis; Nikolaos Vassos; Klaus Weber; Klaus E Matzel; Konstantinos Papadopoulos; Georgios Koukis; Evangelos Perrakis; Roland S Croner; Werner Hohenberger
Journal:  Arch Med Sci       Date:  2018-11-29       Impact factor: 3.318

Review 4.  Recurrence Risk after Radical Colorectal Cancer Surgery-Less Than before, But How High Is It?

Authors:  Erik Osterman; Klara Hammarström; Israa Imam; Emerik Osterlund; Tobias Sjöblom; Bengt Glimelius
Journal:  Cancers (Basel)       Date:  2020-11-09       Impact factor: 6.639

5.  Has the increase in the regional nodes evaluated improved survival rates for patients with locoregional colon cancer?

Authors:  Zhongyi Zhou; Hong Zhu; Wenxue Liu; Fengbo Tan; Qian Pei; Lilan Zhao; Chenglong Li; Dan Wang; Yuan Zhou; Huan Peng; Haiping Pei; Yuqiang Li
Journal:  J Cancer       Date:  2021-03-05       Impact factor: 4.207

6.  Neoadjuvant Treatment Lowers the Risk of Mesopancreatic Fat Infiltration and Local Recurrence in Patients with Pancreatic Cancer.

Authors:  Sami-Alexander Safi; Lena Haeberle; Alexander Rehders; Stephen Fung; Sascha Vaghiri; Christoph Roderburg; Tom Luedde; Farid Ziayee; Irene Esposito; Georg Fluegen; Wolfram Trudo Knoefel
Journal:  Cancers (Basel)       Date:  2021-12-23       Impact factor: 6.639

Review 7.  Finding Waldo: The Evolving Paradigm of Circulating Tumor DNA (ctDNA)-Guided Minimal Residual Disease (MRD) Assessment in Colorectal Cancer (CRC).

Authors:  Sakti Chakrabarti; Anup Kumar Kasi; Aparna R Parikh; Amit Mahipal
Journal:  Cancers (Basel)       Date:  2022-06-23       Impact factor: 6.575

8.  Laparoscopic modified mesocolic excision with central vascular ligation in right-sided colon cancer shows better short- and long-term outcomes compared with the open approach in propensity score analysis.

Authors:  Jung Kyong Shin; Hee Cheol Kim; Woo Yong Lee; Seong Hyeon Yun; Yong Beom Cho; Jung Wook Huh; Yoon Ah Park; Ho-Kyung Chun
Journal:  Surg Endosc       Date:  2017-11-03       Impact factor: 4.584

9.  Robotic Complete Mesocolic Excision (CME) is a safe and feasible option for right colonic cancers: short and midterm results from a single-centre experience.

Authors:  Najaf Siddiqi; Samuel Stefan; Ravish Jootun; Ioannis Mykoniatis; Karen Flashman; Richard Beable; Gerald David; Jim Khan
Journal:  Surg Endosc       Date:  2021-01-05       Impact factor: 4.584

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.